Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1,499,334
-
Shares change
-
+221,695
-
Total reported value, excl. options
-
$5,140,899
-
Value change
-
+$692,978
-
Put/Call ratio
-
235%
-
Number of buys
-
12
-
Number of sells
-
-11
-
Price
-
$3.43
Significant Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q4 2020
35 filings reported holding CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock as of Q4 2020.
CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,499,334 shares
of 45,782,552 outstanding shares and own 3.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (343,011 shares), VANGUARD GROUP INC (305,602 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (181,753 shares), NORTHERN TRUST CORP (136,814 shares), GEODE CAPITAL MANAGEMENT, LLC (121,846 shares), Bank of New York Mellon Corp (89,249 shares), GSA CAPITAL PARTNERS LLP (79,091 shares), MORGAN STANLEY (55,607 shares), MILLENNIUM MANAGEMENT LLC (49,357 shares), and CITADEL ADVISORS LLC (36,703 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.